Jing Chen, PhD

Professor, Hematology & Medical Oncology

Emory University School of Medicine

Director, Division of Basic & Translational Science

Emory University School of Medicine

Associate Director of Research, Division of Hematology

Emory University School of Medicine

Co-Leader, Cancer Cell Biology Research Program

Winship Cancer Institute of Emory University

Office: Winship Cancer Institute of Emory University

Phone: (404) 778-5274

Fax: (404) 778-5520

Email: jchen@emory.edu

Additional Contact Information

Additional Websites


Jing Chen, PhD, is Professor and Director of the Division of Basic & Translational Science in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Chen serves as Co-Leader of the Cancer Cell Biology Research Program at Winship Cancer Institute of Emory University.

Dr. Chen obtained his PhD in Biochemistry and Cell Biology at Emory University, and was trained as an HHMI Postdoctoral Fellow in Dr. Gary Gilliland's laboratory at Harvard Medical School before joining Winship Cancer Institute in 2004.

Dr. Chen has earned numerous prestigious awards including American Cancer Society Basic Research Scholar Award, The Leukemia & Lymphoma Society Scholar Award and Georgia Cancer Coalition Distinguished Cancer Scholar Award. In 2014, he was named a Winship 5K Scholar. He is also the recipient of the 2016 Distinguished Alumnus Award from the Graduate Division of Biological and Biomedical Sciences at Laney Graduate School of Emory University, and of the 2016-2017 Winship Research Mentorship Award.


Dr. Chen's research focus includes the metabolic reprogramming and rewiring in cancer cells and the mechanism-based understanding of the pathogenic links between diet and cancer. His research is funded by National Institutes of Health, American Cancer Society, The Leukemia & Lymphoma Society and other notable foundations.

His team is interested in elucidating the mechanistic basis of diet-fueled "metabolic rewiring" that is specifically required by oncogenic mutations for tumor growth, and the underlying mechanisms by which diet-derived nutrients and metabolic abnormalities associated with metabolic disorders/diseases influence cancer initiation, progression, and responses to therapies. These studies will provide mechanistic insights that inform not only reliable diet advice for lower cancer risk, but also development of novel anti-metabolism targeted therapies for cancer treatment.


Dr. Chen has extensive publications in major peer-reviewed journals such as Cancer Cell, Molecular Cell, Cell Metabolism, Nature Cell Biology, Nature Chemistry, Nature Communications, Science Signaling, Journal of Clinical Investigation, PNAS and Blood. He also serves as a reviewer in many study sections of NIH/NCI, Department of Defense, and American Cancer Society.